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Summary
F1L is a functional Bcl-2 homologue that inhibits
apoptosis at the mitochondria during vaccinia
infection. However, the extent and timing of cell
death during DF1L virus infection suggest that
additional viral effectors cooperate with F1L to
limit apoptosis. Here we report that vaccinia
growth factor (VGF), a secreted virulence factor,
promotes cell survival independently of its role in
virus multiplication. Analysis of single and double
knockout viruses reveals that VGF acts synergis-
tically with F1L to protect against cell death during
infection. Cell survival in the absence of F1L is
dependent on VGF activation of the epidermal
growth factor receptor. Furthermore, signalling
through MEK kinases is necessary and sufficient
for VGF-dependent survival. We conclude that VGF
stimulates an epidermal growth factor receptor-
MEK-dependent pro-survival pathway that syner-
gizes with F1L to counteract an infection-induced
apoptotic pathway that predominantly involves the
BH3-only protein Bad.
Introduction
Upon virus infection most cells attempt to undergo cell
death as a means to limit viral spread. To circumvent this,
viruses have evolved numerous mechanisms to inhibit
apoptosis, thereby prolonging the survival of infected cells
to facilitate productive replication (Roulston et al., 1999).
Consequently, many viruses encode sequence homo-
logues of anti-apoptotic members of the Bcl-2 family
(Cuconati and White, 2002). Like their cellular counter-
parts, these viral proteins inhibit the pro-apoptotic Bak
and Bax from executing mitochondrial-dependent cell
death. Bcl-2 sequence homologues are noticeably absent
from most poxvirus genomes. However, the Lepripox
virus myxoma encodes a protein, M11L, which prevents
apoptosis by inhibiting Bak and Bax (Wang et al., 2004;
Su et al., 2006). Similarly, vaccinia virus encodes a mito-
chondrially targeted protein, F1L, which is able to inhibit
apoptosis by binding and preventing activation of Bak and
Bim (Wasilenko et al., 2005; Postigo et al., 2006; Taylor
et al., 2006). This anti-apoptotic activity is dependent on
a BH3-like, Bak-binding domain, suggesting that F1L acts
as a functional Bcl-2 homologue (Postigo et al., 2006).
In the absence of F1L cells succumb to cell death much
earlier than during infection with Western Reserve (WR),
even though replication and spread appear unaffected
(Wasilenko et al., 2005; Postigo et al., 2006). Further-
more, it has been reported that infection triggers a cellular
suicide response shortly after virus entry (Ramsey-Ewing
and Moss, 1998) and before F1Lis detected at 2–3 h after
infection (Postigo et al., 2006). Given this, we wondered
whether an additional early viral protein cooperates
with F1L to prevent cell death. One possible candidate
expressed early during infection is the highly conserved
vaccinia growth factor (VGF), an epidermal growth
factor (EGF)-like growth factor (Brown et al., 1985). EGF
belongs to a family of ligands that is conserved from
invertebrates to mammals (Yarden and Sliwkowski,
2001). All these ligands induce ligand-induced homo-
and heterodimerization of the ErbB1-4 receptor tyrosine
kinases leading to activation of Ras-MEK-ERK, phospho-
lipase C and STAT pathways (Yarden and Sliwkowski,
2001). EGF receptor (EGFR) (ErbB1)-mediated signall-
ing stimulates cell proliferation and differentiation, but it
can also act to inhibit apoptosis (Sibilia et al., 2000; Jost
et al., 2001a; Yarden and Sliwkowski, 2001).
Vaccinia growth factor is secreted early during infection.
It binds EGFR homodimers with reduced affinity, a feature
that enhances signalling by attenuating receptor inac-
tivation (Tzahar et al., 1998). Deletion of VGF from the
vaccinia genome (DVGF) leads to reduced plaque size
in vitro and reduced virulence in vivo, consistent with a
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cellular microbiologyrole in virus replication (Buller et al., 1988a; b). Further-
more, secreted VGF acts as a mitogen that primes non-
infected cells for subsequent infection (Buller et al.,
1988a; b). In addition to this non-cell autonomous effect,
VGF activates ERK in infected cells, which is required
for efficient viral replication and multiplication (Andrade
et al., 2004).
In this study we report that VGF promotes survival
of vaccinia-infected cells by inducing an EGFR-MEK-
dependent pathway that mimics host survival signals in
epithelial cells. Furthermore, by using the DF1L-sensitized
genetic background we show that VGF and F1L act syn-
ergistically to counteract a cell death pathway predomi-
nantly dependent on the BH3-only protein Bad.
Results
VGF and F1L act synergistically to prevent
infection-induced cell death
In order to test whether growth factor signalling by VGF
contributes to cell survival during infection, we deleted the
F1L gene from the DVGF virus. Infection with the resulting
double mutant virus (DF1L/VGF) leads to inhibition of
phosphorylation of the EGFR, indicating that the virus,
like DVGF, was unable to induce growth factor signalling
(Fig. 1A). Consistent with previous observations using
the single-deletion strains, we found that WR and DF1L
infection produces large plaques, while both the DVGF
and DF1L/VGF viruses form small plaques (Fig. 1B).
Re-infection assays with WR, DVGF, DF1L or DF1L/VGF
viruses conﬁrmed that the absence of VGF results in a
reduction in infectious particle production consistent with
the plaque phenotype and the replication defect caused
by the absence of VGF (Fig. 1B). Thus, absence of F1L in
the double mutant does not exacerbate the replication
defect reported for the DVGF virus.
To determine if VGF also promotes cell survival, we
examined whether infection with the DVGF virus resulted
in increased apoptosis using quantitative immunoﬂuores-
cence assays that detect increases in fragmented nuclei,
accumulation of activated Bax and loss of mitochondrial
cytochrome C (Fig. 2A). All three assays revealed a small
but signiﬁcant increase in apoptosis after DVGF infection
(Fig. 2B). A more pronounced level of cell death was
observed in DF1L infection cells (Fig. 2B). Moreover,
infection with the DF1L/VGF virus resulted in a synergistic
increase in cell death in all three assays (Fig. 2B). The
increase in cell death in the absence of VGF or F1L also
correlated with classical biochemical hallmarks of apop-
tosis (Fig. 2C). Infection with the WR did not induce poly
(ADP-ribose) polymerase (PARP) cleavage or activation
of caspase-3. Loss of VGF resulted in a small but detect-
able cleavage of PARP and caspase-3 activation, while
deletion of F1L induced pronounced PARP cleavage
and activation of caspase-3. Cleavage of these apoptotic
markers was signiﬁcantly enhanced in the absence
of both F1L and VGF during DF1L/VGF infections
(Fig. 2C). Taken together, our results show that infection
with the DF1L/VGF virus leads to a synergistic increase
in cell death, consistent with a role for VGF in promoting
cell survival during infection.
VGF mediates cell survival in an
EGFR-dependent manner
It has been reported that VGF preferentially binds
EGFR-containing hetero- and homodimers. To establish
whether VGF stimulates cell survival solely via the EGFR
receptor, we examined the effect of AG1478, a speciﬁc
EGFR inhibitor, and DAPH, an inhibitor of ErbB1/2, on the
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Fig. 1. Loss of F1L does not reduce DVGF plaque size or virus
production.
A. Western blot analysis of HeLa cell lysates infected with the
indicated virus strains for 20 h post infection reveals that viruses
encoding VGF phosphorylate the EGFR (P-Tyr). EGFR is not
activated by DVGF and DF1L/VGF, which contain a LacZ reporter
in the VGF loci (Ponceau staining).
B. Representative images of plaque formation by the indicated
virus strains in BSC-1 cells visualized with crystal violet 4 days post
infection. The graph shows quantitative analysis of infectious virus
(plaque forming units ml
-1) present in the culture supernatant of
the indicated virus strains 24 h post infection determined using
standard plaque assays on BSC-1 cells. The error bars represent
standard error of the mean and ** indicates P < 0.01.
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DF1L/VGF viruses (Fig. 3A and B). Western blot analysis
revealed that AG1478 inhibited activation of the ERK
pathway due to WR infection (Fig. 3B). Both AG1478 and
DAPH treatment substantially increased cell death during
DF1L infection to levels that were similar to those
observed with the DF1L/VGF virus (Fig. 3A). This corre-
lates with AG1478 blockade of vaccinia-induced EGFR
signalling and downstream ERK activation. In addition,
activation of ERK by phosphorylation is severely reduced
in the absence of VGF (Fig. 3B). Furthermore, similar to
the corresponding cell death counts, analysis of apoptosis
markers revealed an increase in PARP and caspase-3
cleavage in lysates from DF1L-infected cells to the levels
Fig. 2. Loss of VGF increases cell death in the absence of F1L.
A. Representative immunoﬂuorescence images illustrating the changes in apoptosis status during infection with the indicated virus at 20 h post
infection. Yellow arrowheads indicated DNA fragmentation (DNA, left column), Mitochondrial Bax activation (Active-Bax, middle column) and
release of cytochrome c from mitochondria (cytochrome c, right column).
B. Quantiﬁcation of cell death in HeLa cells infected with the indicated virus at 20 h post infection. Error bars represent standard error of the
mean, *P < 0.05 and ***P < 0.001.
C. Western blot analysis of infected cells at 20 h post infection indicates that there is increasing amounts of processed PARP and cleaved
caspase-3 during DVGF, DF1L and DF1L/VGF infections.
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Fig. 3. VGF mediates cell survival via the EGFR.
A. Quantitative analysis of DNA fragmentation in HeLa cells infected for 20 h with the indicated virus strains in the presence or absence
of the EGFR inhibitors AG1478 and DAPH.
B. Western blot analysis of cells infected for 20 h with the indicated virus in the presence (+) or absence (-) of AG1478 reveals that loss
of EGFR signalling reduces ERK phosphorylation and increases PARP processing as well as caspase-3 cleavage.
C. Quantitative analysis of cell death in HeLa cells infected with indicated virus strains for 20 h in the presence or absence of the VGF
peptide. Error bars represent standard error of the mean, *P < 0.05 and ***P < 0.001.
D. Western blot analysis of infected cells in the presence (+) or absence (-) of the VGF peptide reveals that activation of EGFR signalling
promotes ERK phoshorylation and reduces PARP processing and caspase-3 cleavage during DVGF and DF1L/VGF infection.
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tional effects on PARP and caspase-3 cleavage in cells
infected with the DF1L/VGF virus (Fig. 3B).
Having established that VGF-mediated survival
depends on the EGFR, we next asked whether exo-
genously supplied VGF is sufficient to rescue F1L-
independent cell survival during DF1L/VGF infection.
Addition of VGF led to an increase in cell survival in
DVGF-infected cells, but had no effect on DF1L-infected
cells (Fig. 3C). Moreover, VGF decreased cell death
in DF1L/VGF-infected cells to levels similar to DF1L
(Fig. 3C). Addition of the synthetic VGF peptide also
stimulated ERK phosphorylation for the duration of
the experiment (Fig. 3D). Furthermore, VGF application
inhibited PARP and caspase-3 cleavage in DF1L/VGF-
infected cells (Fig. 3D). Together, our results demonstrate
that VGF signalling via the EGFR is sufficient to promote
F1L-independent cell survival during infection.
Late gene expression is dispensable for
VGF-mediated cell survival
Expression of VGF is required for efficient replication
and late gene expression. It is possible therefore that
VGF mediates cell survival indirectly, for instance, if it is
required for expression of a late gene that promotes cell
survival. To exclude whether this is the case, we infected
cells with the four different viruses in the presence of
cytosine arabinoside (AraC), an inhibitor of DNA replica-
tion and late gene expression. AraC would be expected
to exacerbate cell death if VGF survival depends on
late gene expression. However, Western blot analysis of
infected cell lysates treated with AraC showed no further
increase in PARP cleavage or caspase-3 processing in
any of the virus strains (Fig. 4A). This suggests that VGF,
as well as F1L exert their effects on cell survival indepen-
dently of late gene expression.
Addition of exogenous VGF peptide is sufficient to
limit cell death during DF1L/VGF infection to the levels
observed with DF1L (Fig. 3C). Addition of AraC did not
increase PARP and caspase-3 cleavage in DF1L/VGF-
infected cells in the presence of the VGF peptide
(Fig. 4B). These experiments using an exogenously
added peptide demonstrate that VGF promotes survival
independently of late gene expression.
MEK is necessary and sufficient to mediate
VGF-dependent survival
Activation of the EGFR induces cell survival by stimulat-
ing the Ras-MEK-ERK and phosphoinositol 3-phosphate
kinase (PI3K)-Akt pathways. ERK is activated by phos-
phorylation in response to vaccinia virus infection, and
this increase in phosphorylation is severely reduced in the
absence of VGF (Figs 3B and 5A). In contrast, we failed to
see changes in Akt phosphorylation throughout infection
irrespective of the viral strain (Fig. 5A). We therefore
investigated whether the Ras-MAPK pathway contributes
to VGF-dependent survival.
To determine if VGF-mediated survival is dependent
on activation of the Ras-MAPK pathway, we examined
the effect of the speciﬁc MEK1/2 inhibitors UO126 and
PD98059 during infection with WR and the deletion
strains. Treatment with either drug had no effect on DVGF
or DF1L/VGF-induced cell death, but increased DF1L-
induced cell death to similar levels as observed with
the DF1L/VGF virus (Fig. 5B). WR and DF1L-mediated
ERK activation was blocked in the presence of UO126
(Fig. 5C). Western blot analysis of the extent of PARP and
caspase-3 cleavage conﬁrmed that inhibition of MEK1/2
by UO126 resulted in increased apoptosis in DF1L
infected cells (Fig. 5C). Conversely, addition of VGF
peptide to DF1L/VGF-infected cells activated ERK and at
the same time reduced PARP and caspase-3 cleavage
(Fig. 5D). The addition of U0126 blocked ERK phospho-
rylation by VGF peptide and abrogated the VGF-mediated
decrease in DF1L/VGF-induced PARP and caspase-3
cleavage (Fig. 5D).
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Fig. 4. VGF stimulates cell survival independent of late gene
expression.
A. Western blot analysis of infected cells in the presence (+)o r
absence (-) of AraC reveals that PARP processing and caspase-3
cleavage is unaffected by inhibition of late gene expression.
AraC-mediated inhibition of late gene expression was conﬁrmed by
the absence of A27L, a late viral protein.
B. Western blot analysis of DF1L/VGF-infected cells in the
presence (+) or absence (-) of the VGF peptide reveals that the
reduction in PARP processing and caspase-3 cleavage by VGF
is not inhibited by the presence (+) of AraC.
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would be sufficient to promote F1L-independent cell sur-
vival during infection in the absence of an upstream VGF
signal. To ensure that cell death was only quantiﬁed in
infected HeLa cells expressing MEK-EE we used GFP
expression as a co-reporter for cell transfection. This
analysis reveals that expression of MEK-EE did not impact
on DF1L-induced death (Fig. 6A). In contrast, cell death in
DF1L/VGF-infected cells was reduced to similar levels as
observed in DF1L infections (Fig. 6A). Western blot analy-
sis revealed that there was a corresponding decrease
in infection-induced PARP and caspase-3 cleavage in
DF1L/VGF cells expressing MEK-EE (Fig. 6B). Our data
show that activation of MEK downstream of the EGFR is
B
D
ppERK1/2
cleaved PARP
ERK1/2
A36R
- + + + + - - -
WR ΔVGF ΔF1L/VGF ΔF1L
A36R
ERK1/2
ppERK1/2
cleaved PARP
U0126
A
Akt
WR ΔVGF
02 2 4 8 20 24 4 8 20 24
pAkt
ΔF1L/VGF
248 2 0 2 4 0 248 2 0 2 4 0
ΔF1L
ppERK1/2
ERK1/2
0
C
h.p.i.
active Casp-3 active Casp-3
WR
ΔVGF
ΔF1L/VGF
ΔF1L
DMSO
U0126
PD98059
+ + - -
- - ++U0126
VGF
ΔF1L/VGF
C
e
l
l
 
d
e
a
t
h
 
(
%
) ***
***
Fig. 5. Activated ERK is necessary for VGF-dependent cell survival.
A. Western blot analysis of HeLa cells infected with indicated virus reveals that ERK is phosphorylated during WR and DF1L but not DVGF
and DF1L/VGF infection. The status of Akt phosphorylation remains relatively constant throughout infection with all strains.
B. Quantitative analysis of cell death in HeLa cells infected with indicated virus in the presence or absence of the MEK1/2 inhibitor UO126.
Error bars represent standard error of the mean and ***P < 0.001.
C. Western blot analysis of infected cells in the presence (+) or absence (-) of UO126 reveals that loss of MEK1/2 activity results reduced
ERK phosphorylation and an increase in processed PARP and cleaved caspase-3 in DF1L infected cells.
D. Western blot analysis of DF1L/VGF-infected cells in the presence (+) or absence (-) of VGF peptide reveals that peptide-mediated
reduction in PARP processing and caspase-3 cleavage is inhibited by the presence (+) of UO126.
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vival during infection.
VGF and F1L cooperatively block infection-induced
cell death via Bad
It is at present unclear what molecular trigger induces
vaccinia-induced cell death when either F1L or VGF are
absent. If VGF and F1L synergize to prevent cell death,
the loss of a crucial host component mediating cell death
should abrogate cell death in DF1L/VGF cells. Bad and
Bim are two BH3-only pro-apoptotic members of the Bcl-2
family that are known to be regulated by growth factor
signalling (Puthalakath and Strasser, 2002). We therefore
tested whether Bad and Bim might be responsible for
mediating infection-induced cell death by examining the
effect of their downregulation through RNAi-mediated
ablation (Fig. 7). Remarkably, for the three deletion
viruses, we found that loss of Bad resulted in a dramatic
reduction in cell death to similar levels to that observed
in WR infections (Fig. 7A). In contrast, knockdown of Bim
only resulted in a signiﬁcant reduction in cell death in
DF1L/VGF-infected cells. These results were consistent
with Western blot analysis of apoptosis markers (Fig. 7B).
Loss of Bad signiﬁcantly reduced PARP and caspase-3
cleavage in both DF1L and DVGF-infected cells. In DF1L/
VGF-infected cells loss of Bim resulted in a small reduc-
tion of cell death, whereas lack of Bad resulted in a large
reduction in PARP and caspase-3 cleavage (Fig. 7). Our
data demonstrate that VGF and F1L cooperate to sup-
press vaccinia-induced cell death through a pathway that
primarily involves Bad.
Discussion
The EGF stimulates complex signalling networks to
promote proliferation, differentiation, migration or survival
in a context-dependent manner (Yarden, 2001; Yarden
and Sliwkowski, 2001). Consistent with its critical role
in cell proliferation and survival components of the EGF
signalling networks are frequently constitutively activated
within tumours (Olayioye et al., 2000). It is not surprising
given that viruses are also dependent on cell survival
for productive replication that they have evolved elegant
mechanisms to inhibit infection-induced cell death (Roul-
ston et al., 1999). Our data now clearly show that vaccinia
virus stimulates the EGF signalling pathway to enhance
cell survival during infection.
Previous studies have shown that VGF, which is
secreted early during infection, induces continuous acti-
vation of the EGFR signalling throughout the virus infec-
tion cycle as a consequence of its lower affinity for the
receptor (Tzahar et al., 1998). This prolonged EGFR
activation and signalling would ensure that the infected
cell receives a sustained survival signal that antagonizes
infection-induced cell death. In accordance with previous
studies (Andrade et al., 2004), we have shown that trig-
gering signalling pathways by VGF involves a sustained
activation of the ERK pathway during infection. Further-
more, our data indicate that activation of the EGFR/MEK
pathway is the downstream signalling cascade stimulated
by VGF sufficient to elicit a cell survival signal during
infection (Figs 5 and 6). Survival pathways stimulated by
growth factors in many biological systems are frequently
PI3K-Akt-dependent (Cantley, 2002). However, phos-
phorylation of EGFR is known to only weakly activate the
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Fig. 6. Activated ERK is sufficient for VGF-dependent cell survival.
A. Quantitative analysis of cell death in HeLa cells 20 h post
infection with indicated virus in the presence or absence of
constitutively active MEK1/2 (MEK-EE). Error bars represent
standard error of the mean and ***P < 0.001.
B. Western blot analysis of infected cells in the presence (+)o r
absence (-) of MEK-EE reveals that activation of MEK1/2
increases ERK phosphorylation in all strains and decreases PARP
processing as well as caspase-3 cleavage during DF1L/VGF
infection.
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this we did not observe any changes in activation of the
PI3K-Akt pathway during vaccinia infection (Fig. 5A). This
is in contrast to the situation observed with several RNA
viruses, as well as herpes viruses, which stimulate PI3K-
Akt signalling to inhibit apoptosis via intracellular adaptors
and decoys (Cooray, 2004).
The role of MEK in EGFR-dependent cell survival has
previously been described in keratinocytes, with inhibition
of MEK resulting in apoptosis (Jost et al., 2001b). In these
cells, survival in the absence of matrix-derived signals is
dependent on EGFR signalling, which is required to main-
tain a high-level expression of the anti-apoptotic protein
Bcl-xL (Jost et al., 2001a). In other epithelial cell types,
EGFR-dependent ERK activation is thought to promote
cell survival by preventing upregulation of the pro-
apoptotic protein Bim (Reginato et al., 2003).
Our data reveal that VGF, in concert with F1L, inhibits
apoptosis by activating the EGFR/MEK pathway to coun-
teract a cell death pathway principally through the BH3-
only protein Bad (Fig. 7). It has been previously reported
that during vaccinia infection Bim is a signiﬁcant inducer
of cell death in the absence of F1L (Taylor et al., 2006).
We found that Bim plays only a modest or redundant
role in the induction of cell death by DF1L/VGF infection
(Fig. 7). Whether these results are attributable to assay/
cell type differences or caused by differences between
acute siRNA-mediated knockdown versus knockout
cells, which may have adapted, is unclear. Therefore, we
cannot formally exclude that incomplete Bim knockdown
allowed apoptosis to progress as normal, although our
ﬁndings are consistent with the observation that cell death
induced by MVA-DF1L infection is not reduced in Bim–/–
MEF cells (Fischer et al., 2005).
In contrast to Bim, loss of Bad signiﬁcantly reduced
infection-induced cell death by all our virus strains (Fig. 7).
It is thought that vaccinia induces apoptosis via several
routes (Fischer et al., 2005; Taylor and Barry, 2006). For
instance, vaccinia dsRNA-induced apoptosis depends
exclusively on the BH3-only protein Noxa and is blocked
by E3L (Fischer et al., 2005). Notably, in the context of
DE3L infection cell death is not inhibited by the presence
Fig. 7. Infection-induced cell death is
principally dependent on Bad.
A. Quantitative analysis of cell death in HeLa
cells transfected with the indicated siRNA
against Bim and Bad at 20 h post infection.
Error bars represent standard error of the
mean, *P < 0.05 and ***P < 0.001.
B. Western blot analysis of cells infected with
the indicated virus after RNAi-mediated
knockdown of Bim or Bad reveals that loss
of Bad results in reduced PARP processing
and caspase-3 cleavage.
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Vaccinia infection, in addition, triggers a Bad-dependent
cell death pathway that is antagonized by VGF and F1L.
It would be of interest whether VGF and F1L directly
inhibit Bad or at some point downstream of Bad to inhi-
bit cell death. Interestingly, no role for Bad in vaccinia-
induced cell death has so far been reported. Bad binds
to the pro-survival proteins Bcl-2, Bcl-w and Bcl-xL, thus
preventing their inhibition of Bak and/or Bax (Chen et al.,
2005). F1L may inhibit Bad by direct sequestration as
observed for Bim (Taylor et al., 2006), yet no Bad binding
to F1L has been reported thus far. Alternatively, F1L could
represent a Bcl-xL-like molecule that retains a high Bak-
binding affinity, but unlike host Bcl-xL, does not interact
with BH3-only proteins, including Bad. Thus, while acti-
vated Bad could sequester Bcl-2 pro-survival proteins to
prevent them from neutralizing Bak, F1L would ensure the
continued inactivation of Bak. A similar mechanism has
been proposed for the myxoma virus protein M11L based
on its structure (Kvansakul et al., 2007). Interestingly,
M11L binding to Bak and Bax is required for its survival
promoting activity, yet despite its interaction with Bim, the
latter is not involved in the anti-apoptotic function of M11L
(Kvansakul et al., 2007). While the structure of F1L has
been solved (Kvansakul et al., 2008), it remains to be
established whether a similar mechanism is operating
during vaccinia infection. In contrast to M11L, F1L binds
Bak but not Bax (Wasilenko et al., 2005; Postigo et al.,
2006). It was recently reported that vaccinia N1L, which
structurallyresemblesBcl-2proteins,caninteractwithBax
and Bad (Cooray et al., 2007). It is an intriguing possibility
that N1L and F1L target complimentary sets of Bcl-2 pro-
teins, although functionally N1L is not sufficient to inhibit
the extensive Bad-dependent cell death induced by the
DF1L/VGF virus.
Our study has revealed VGF to be an important inhibitor
of cell death during infection. It will be interesting to test
what targets of the VGF pathway promote survival, includ-
ing potential phosphorylation of viral proteins required for
survival, although our work suggests these would need
to be early proteins. In conclusion, we have shown for the
ﬁrst time that a virus is capable of using two coopera-
tive strategies to suppress a Bad-dependent cell death
pathway: VGF stimulates EGFR/MEK kinase survival
signalling, while F1L inhibits mitochondrial-dependent
cell death.
Experimental procedures
Viruses and cells
We deleted the F1L locus in the DVGF WR strain that lacks both
copies of VGF (open reading frames WR009 and WR210) (Buller
et al., 1988a) using the guanine phosphoribosyl transferase cas-
sette replacement strategy previously used to generate the DF1L
virus (Postigo et al., 2006). The resulting DF1L/VGF virus was
veriﬁed by sequencing and Western blot analysis. Infections of
HeLa cells with vaccinia virus and processing for immunoblot
analysis were as described previously (Postigo et al., 2006).
Infections and cell survival quantiﬁcation
HeLa cells plated on dishes coated with ﬁbronectin were infected
with WR or the recombinant vaccinia virus strains at a multiplicity
ofinfectionof2inOpti-MEMreducedserummediaandprocessed
for microscopy or immunoblot analysis 20 h post infection.All cell
death quantiﬁcation experiments were performed at least three
times, each consisting of a minimum of three counts of over 200
cells each. For western analysis, detached apoptotic cells were
collected and added to the adherent cells before cell lysis.
Drug treatments, transfections and siRNA
HeLa cells were incubated 30 min prior to infection and dur-
ing infection with the following as appropriate: UO126 (10 mM),
PD98059 (36 mM), AG1478 (20 mM), DAPH (15 mM), VGF
peptide (10 nM), AraC (50 mM). HeLa cells were transfected with
pE/L-MEK1.EE together with pE/L-GFP as a transfection reporter
using Effectene according to the manufacturer’s instructions
(Qiagen) before being infected with WR or the deletion virus
strains 2 h later. Cells were processed for immunoblot analysis
20 h after treatments and transfections. HeLa cells were trans-
fected with Bad, Bim or a control non-targeting siRNA (20 nM)
according to the manufacturer’s instructions using Hiperfect
(QIAGEN). One day post transfection, cells were infected with
vaccinia virus and incubated for a further 20 h before being
processed for Western blotting.
Antibodies, reagents and chemicals
The following antibodies were used for Western blotting
according to standard protocols: ERK1/2, phospho-ERK1/2, Akt,
anti-phospho-Akt (Ser473), anti-PARP, anti-active caspase-3 and
anti-Bad (Cell Signalling Technology, Beverly, MA); anti-phospho-
tyrosine (4G10) was purchased from Upstate and anti-Bim (22–
40) was purchased from Calbiochem.Antibodies against the viral
proteins A27L, A36R and F1L have been previously described
(Rodriguez et al., 1985; Röttger et al., 1999; Postigo et al., 2006).
Secondary antibodies for Western blots were goat anti-rabbit or
anti-mouse IgG coupled to horseradish peroxidase (Bio-Rad).
Validated siRNA for Bad (SI02663003) and Bim (SI02655359)
were obtained from Qiagen. siGENOME Non-Targeting siRNA
Pool (D-001206-14-20) was obtained from Dharmacon. pEL-
MEK.EE was obtained by subcloning from pcDNA3-Rab.MEK.EE
(a gift from by Professor P.C. Clarke, Dundee University, Dundee,
UK). UO126 was purchased from Promega, AG1478 was
obtained from Merck. PD98059 was from Calbiochem and
cytosine arabinoside (AraC) was obtained from Sigma. Residues
38–88ofvacciniaWRVGF,correspondingtotheEGF-likedomain
as deﬁned by Tzahar et al. (1998), were synthesized by Cancer
Research UK.
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